Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV-2 infection. We profiled MIS-C, adult COVID-19, and healthy pediatric and adult individuals using single-cell RNA sequencing, flow cytometry, antigen receptor repertoire analysis, and unbiased serum proteomics, which collectively identified a signature in MIS-C patients that correlated with disease severity. Despite having no evidence of active infection, MIS-C patients had elevated S100A-family alarmins and decreased antigen presentation signatures, indicative of myeloid dysfunction. MIS-C patients showed elevated expression of cytotoxicity genes in NK and CD8 + T cells and expansion of specific IgG-expressing plasmablasts. Clinically severe MIS-C patients displayed skewed memory T cell TCR repertoires and autoimmunity characterized by endothelium-reactive IgG. The alarmin, cytotoxicity, TCR repertoire, and plasmablast signatures we defined have potential for application in the clinic to better diagnose and potentially predict disease severity early in the course of MIS-C.

Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe COVID-19. However, the immune signatures associated with immunopathology are poorly understood. Here we use multi-omics single-cell analysis to probe the dynamic immune responses in hospitalized patients with stable or progressive course of COVID-19, explore V(D)J repertoires, and assess the cellular effects of tocilizumab. Coordinated profiling of gene expression and cell lineage protein markers shows that S100Ahi/HLA-DRlo classical monocytes and activated LAG-3hi T cells are hallmarks of progressive disease and highlights the abnormal MHC-II/LAG-3 interaction on myeloid and T cells, respectively. We also find skewed T cell receptor repertories in expanded effector CD8+ clones, unmutated IGHG+ B cell clones, and mutated B cell clones with stable somatic hypermutation frequency over time. In conclusion, our in-depth immune profiling reveals dyssynchrony of the innate and adaptive immune interaction in progressive COVID-19.

No abstract

Polymeric g‐C3N4 is a promising visible‐light‐responsive photocatalyst; however, the fast recombination of charge carriers and moderate oxidation ability remarkably restrict its photocatalytic oxidation efficiency towards organic pollutants. To overcome these drawbacks, a self‐modification strategy of one‐step formaldehyde‐assisted thermal polycondensation of molten urea to prepare carbon‐deficient and oxygen‐doped g‐C3N4 (VC‐OCN) is developed, and the carbon vacancy concentration is well‐controlled by changing formaldehyde dosage. The VC‐OCN catalysts exhibit interesting carbon vacancy concentration‐dependent photocatalytic removal efficiency to p‐nitrophenol (PNP) and atrazine (ATN), in which VC‐OCN15 with appropriate carbon vacancy concentration displays significantly higher pollutant removal efficiency than bulk g‐C3N4. The apparent first‐order rate constant of VC‐OCN15 for PNP and ATN removal is 4.4 and 5.2 times higher than that of bulk g‐C3N4. A combination of the experimental results and theoretic calculations confirm that the synergetic effect of carbon vacancies and oxygen doping sites can not only delay the recombination of charge carriers but also facilitate adsorption of oxygen molecules on the carbon vacancies, which leads to the generation of plentiful active oxygen species including not only superoxide anion radicals but also indirectly formed hydroxyl radicals and singlet oxygen. These active oxygen species play a dominant role in the removal of target pollutants.

A dysregulated immune response against the SARS-CoV-2 virus plays a critical role in severe COVID-19. However, the molecular and cellular mechanisms by which the virus causes lethal immunopathology are poorly understood. Here, we utilize multi-omics single-cell analysis to probe dynamic immune responses in patients with stable or progressive manifestations of COVID-19, and assess the effects of tocilizumab, an anti-IL-6 receptor monoclonal antibody. Coordinated profiling of gene expression and cell lineage protein markers reveals a prominent type-1 interferon response across all immune cells, especially in progressive patients. An anti-inflammatory innate immune response and a pre-exhaustion phenotype in activated T cells are hallmarks of progressive disease. Skewed T cell receptor repertoires in CD8 T cells and uniquely enriched V(D)J sequences are also identified in COVID-19 patients. B cell repertoire and somatic hypermutation analysis are consistent with a primary immune response, with possible contribution from memory B cells. Our in-depth immune profiling reveals dyssynchrony of the innate and adaptive immune interaction in progressive COVID-19, which may contribute to delayed virus clearance and has implications for therapeutic intervention.